Peptide administration for lung fibrosis treatment using formulation based on medusa technology. develop a sustained release formulation os p144 or p17, loquid or freeze-dried form, for subcutaneous administration route and carry on preclinical and clinical trials.
Invitrotek ltd. Sti. (Istanbul, turkey) and pronto diagnostics ltd. (Tel aviv, israel) will collaborate in developing an assay, based on the targeted next generation sequencing to detect mutations in all thalassemia cases.
To discover and develop a natural product for the management of a specific plant disease - "fire blight" - offering an alternative or complementary approach to the use of chemical control.
A study to develop a device & algorithm to analyze oxidative stress & proteomic profile in a ivf laboratory and investigate and validate the use of both as biomarkers for embryo viability in human ivf and its use as an additional markers to the existing morphokinetics markers provided by time lapse
The primary goal of the project evita is to develop an innovative dermatological product formulation dermavit for treatment of specific severe cutaneous side effects induced by therapy in oncology patients and to improve their quality of life.
Aim of the project is to find markers of response of a potential treatment of nash like aramchol through metabolomic signature study of the serum of the patients participating in phase iib double blind, randomized clinical trial.
The project aims for the development of a new legume variety that will bring agronomic sustainability and gives the starting material for a new and healthy bakery and feed products.
The mission of the consortium is to utilize state-of-the-art pharmaceutical approaches and develop tnf-alpha-binding protein-imprinted polymers for the specific elimination of tnf-alpha from the gastrointestinal tract hence improving the therapy of currently untreatable crohn's disease.
The project aims at the development of software support for mrgfus treatments of prostate cancer comprising 3d visualization, interactive treatment planning, and automatic mr image quality assurance.
The project aims the development of generic purification procedures to obtain endotoxin standards, the development of analytical test kits to quantify endotoxins in liquid formulations and the development of endotoxin specific filter materials to purify liquid formulations from endotoxins.